JP2016523969A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016523969A5 JP2016523969A5 JP2016525428A JP2016525428A JP2016523969A5 JP 2016523969 A5 JP2016523969 A5 JP 2016523969A5 JP 2016525428 A JP2016525428 A JP 2016525428A JP 2016525428 A JP2016525428 A JP 2016525428A JP 2016523969 A5 JP2016523969 A5 JP 2016523969A5
- Authority
- JP
- Japan
- Prior art keywords
- endothelin
- disease
- pharmaceutical composition
- receptor agonist
- composition according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2020179020A JP7385924B2 (ja) | 2013-07-08 | 2020-10-26 | エンドセリンｂ受容体アゴニストを用いた、神経精神疾患を治療するための組成物 |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361843702P | 2013-07-08 | 2013-07-08 | |
| US61/843,702 | 2013-07-08 | ||
| US201361902935P | 2013-11-12 | 2013-11-12 | |
| US61/902,935 | 2013-11-12 | ||
| PCT/US2014/045748 WO2015006324A2 (en) | 2013-07-08 | 2014-07-08 | Compositions and methods for treating neuropsychiatric disorders using an endothelin-b receptor agonist |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020179020A Division JP7385924B2 (ja) | 2013-07-08 | 2020-10-26 | エンドセリンｂ受容体アゴニストを用いた、神経精神疾患を治療するための組成物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2016523969A JP2016523969A (ja) | 2016-08-12 |
| JP2016523969A5 true JP2016523969A5 (https=) | 2017-08-10 |
| JP6928450B2 JP6928450B2 (ja) | 2021-09-01 |
Family
ID=52280704
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016525428A Active JP6928450B2 (ja) | 2013-07-08 | 2014-07-08 | エンドセリンｂ受容体アゴニストを用いた、神経精神疾患を治療するための組成物及び方法 |
| JP2020179020A Active JP7385924B2 (ja) | 2013-07-08 | 2020-10-26 | エンドセリンｂ受容体アゴニストを用いた、神経精神疾患を治療するための組成物 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020179020A Active JP7385924B2 (ja) | 2013-07-08 | 2020-10-26 | エンドセリンｂ受容体アゴニストを用いた、神経精神疾患を治療するための組成物 |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US10561704B2 (https=) |
| EP (1) | EP3019242B1 (https=) |
| JP (2) | JP6928450B2 (https=) |
| CN (2) | CN105682741A (https=) |
| AU (1) | AU2014287427B2 (https=) |
| BR (1) | BR112016000431A8 (https=) |
| CA (2) | CA3171883C (https=) |
| ES (1) | ES2825101T3 (https=) |
| PL (1) | PL3019242T3 (https=) |
| WO (1) | WO2015006324A2 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2010241564B2 (en) | 2009-04-30 | 2014-07-31 | Midwestern University | Novel therapeutic treatments using centhaquin |
| PL3813942T3 (pl) * | 2018-05-03 | 2024-07-22 | Midwestern University | Kompozycja zawierająca centachinę lub jej sól do zastosowania w leczeniu osobnika cierpiącego na ostre pogorszenie czynności nerek |
| US20240207356A1 (en) * | 2022-12-26 | 2024-06-27 | Pharmazz, Inc. | Composition and method for wound healing and repair of damaged nerves |
| KR20260005957A (ko) * | 2023-04-26 | 2026-01-12 | 바이오셀즈(베이징) 바이오테크 코., 엘티디. | 폴리펩티드 및 이의 응용 |
| US20250000934A1 (en) | 2023-06-28 | 2025-01-02 | Pharmazz, Inc. | Lyophilized sovateltide-based injectable formulation and method for preparation thereof |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3954987A (en) | 1972-12-22 | 1976-05-04 | Sandoz, Inc. | 2-Alkyl-4-substituted amino-quinazolines and nitrates thereof in the treatment of myocardial shock |
| US3983121A (en) | 1974-07-01 | 1976-09-28 | Council Of Scientific And Industrial Research | 1-Substituted 4-(β-2-quinolylethyl)piperazines and 1,2,3,4-tetrahydroquinolyl-ethyl analogues thereof |
| DE2557784C2 (de) | 1975-12-22 | 1986-04-17 | Hoechst Ag, 6230 Frankfurt | Forskolin, Verfahren zu dessen Gewinnung und diese Verbindung enthaltende pharmazeutische Präparate |
| US4761417A (en) | 1982-05-14 | 1988-08-02 | Maroko Peter R | Compounds, compositions and method of treatments for improving circulatory performance |
| US5055470A (en) | 1989-06-01 | 1991-10-08 | Bristol-Myers Squibb Co. | Method of treatment of ischemia in brain |
| US5922681A (en) | 1992-09-14 | 1999-07-13 | Warner-Lambert Company | Endothelin antagonists |
| US20040063719A1 (en) | 1998-08-26 | 2004-04-01 | Queen's University At Kingston | Combination therapy using antihypertensive agents and endothelin antagonists |
| US6545048B1 (en) * | 1999-06-29 | 2003-04-08 | California Institute Of Technology | Compositions and methods of treating cancer using compositions comprising an inhibitor or endothelin receptor activity |
| US6113915A (en) | 1999-10-12 | 2000-09-05 | Allergan Sales, Inc. | Methods for treating pain |
| SE0004455D0 (sv) * | 2000-12-01 | 2000-12-01 | Milos Pekny | Method for neuron regeneration in the central nervous system |
| WO2002049630A2 (en) | 2000-12-21 | 2002-06-27 | Bristol-Myers Squibb Company | Method for preventing or treating pain by administering an endothelin antagonist |
| US20030232787A1 (en) | 2001-05-08 | 2003-12-18 | Dooley David James | Combinations of an endothelin receptor antagonist and an antiepileptic compound having pain alleviating properties or analgesic |
| WO2003009805A2 (en) * | 2001-07-23 | 2003-02-06 | Brigham And Women's Hospital, Inc. | Analgesic methods using endothelin receptor ligands |
| US7030082B2 (en) | 2001-09-07 | 2006-04-18 | Nobex Corporation | Pharmaceutical compositions of drug-oligomer conjugates and methods of treating disease therewith |
| US7973064B2 (en) | 2001-11-27 | 2011-07-05 | The Board Of Trustees Of The University Of Illinois | Method and composition for potentiating an opiate analgesic |
| US7351692B2 (en) | 2002-06-19 | 2008-04-01 | The Board Of Trustees Of The University Of Illinois | Method and composition for potentiating the antipyretic action of a nonopioid analgesic |
| JP2006508086A (ja) | 2002-10-24 | 2006-03-09 | ザ ボード オブ トラスティーズ オブ ザ ユニバーシティ オブ イリノイ | 固形腫瘍を予防および治療するための方法および組成物 |
| DE60335743D1 (de) * | 2002-11-20 | 2011-02-24 | Neuronova Ab | Verbindungen und verfahren zur erhöhung der neurogenese |
| WO2008043102A2 (en) | 2006-10-06 | 2008-04-10 | Transition Therapeutics Inc. | Vasoactive intestinal polypeptide compositions |
| EP1996222A2 (en) | 2006-03-23 | 2008-12-03 | Amylin Pharmaceuticals, Inc. | Endothelin and endothelin receptor agonists in the treatment of metabolic diseases |
| CN101888851B (zh) * | 2007-08-21 | 2013-11-20 | 美国中西部大学 | 使用内皮缩血管肽b受体激动剂治疗中风或脑血管意外的组合物 |
| CN101374259B (zh) * | 2007-08-22 | 2012-08-08 | 华为技术有限公司 | 实现多媒体彩铃和多媒体彩像业务的方法和装置 |
| KR101418941B1 (ko) * | 2011-04-04 | 2014-07-15 | 서울대학교병원 | 엔도텔린을 유효성분으로 함유하는 허혈성질환 치료용 조성물 |
-
2014
- 2014-07-08 AU AU2014287427A patent/AU2014287427B2/en active Active
- 2014-07-08 EP EP14823205.1A patent/EP3019242B1/en active Active
- 2014-07-08 BR BR112016000431A patent/BR112016000431A8/pt not_active Application Discontinuation
- 2014-07-08 CN CN201480049491.7A patent/CN105682741A/zh active Pending
- 2014-07-08 ES ES14823205T patent/ES2825101T3/es active Active
- 2014-07-08 CA CA3171883A patent/CA3171883C/en active Active
- 2014-07-08 CA CA2917325A patent/CA2917325C/en active Active
- 2014-07-08 CN CN202110467579.2A patent/CN113384701A/zh active Pending
- 2014-07-08 US US14/903,574 patent/US10561704B2/en active Active
- 2014-07-08 PL PL14823205T patent/PL3019242T3/pl unknown
- 2014-07-08 JP JP2016525428A patent/JP6928450B2/ja active Active
- 2014-07-08 WO PCT/US2014/045748 patent/WO2015006324A2/en not_active Ceased
-
2019
- 2019-12-24 US US16/726,427 patent/US20200353031A1/en not_active Abandoned
-
2020
- 2020-10-26 JP JP2020179020A patent/JP7385924B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2016523969A5 (https=) | ||
| JP2016535786A5 (https=) | ||
| CO2019006785A2 (es) | Inhibidores biciclo[1.1.1]pentano de la cinasa de cremallera de leucina dual (dlk) para el tratamiento de enfermedades | |
| AR110747A1 (es) | Compuestos de 5-metil-1,2,4-oxadiazol-3-ilo | |
| EP4306524A3 (en) | Lymphatic system-directing lipid prodrugs | |
| MA50800A (fr) | Nouveaux promédicaments de catécholamine destinés à être utilisés dans le traitement de la maladie de parkinson | |
| MY189740A (en) | Butylphthalide-telmisartan heterocomplex, preparation method and application thereof | |
| CN110036005A (zh) | 酰胺衍生物及其在药物中的应用 | |
| JP2016525095A5 (ja) | 環状ポリペプチド | |
| JP2016510326A5 (https=) | ||
| EA201991374A1 (ru) | Водорастворимое производное эпиаллопрегнанолона и его применение | |
| BR112021017203A2 (pt) | Leucina, acetil leucina e análogos relacionados para o tratamento de doenças | |
| WO2018071741A8 (en) | Sulfoxyalkyl organonitro and related compounds and pharmaceutical compositions for use in medicine | |
| EP3728567A4 (en) | PROCESS FOR DEVELOPMENT OF PHARMACEUTICALS FOR TREATMENT OF NEURODEGENERATIVE DISORDERS | |
| CY1124115T1 (el) | Η χρηση τριβενζοϊκου γλυκερυλιου που περιεχει συνθεση σε νευροεκφυλιστικες διαταραχες | |
| MX2019002444A (es) | Inhibidores de cinasa de cremallera de leucina dual (dlk) para el tratamiento de enfermedades. | |
| EP4414037A3 (en) | Morphinan derivatives for the treatment of opioid delta receptor agonist-related diseases | |
| JP2017505811A5 (https=) | ||
| JP2016515550A5 (https=) | ||
| EP3248603A4 (en) | Pharmaceutical composition for prevention, treatment or delay of alzheimer's disease or dementia containing g protein-coupled receptor 19 agent as active ingredient | |
| JP2016537432A5 (https=) | ||
| JP2019500379A5 (https=) | ||
| HRP20200161T1 (hr) | (r)-3-((3s,4s)-3-fluoro-4-(4-hidroksifenil)piperidin-1-il)-1-(4-metilbenzil)pirolidin-2-on i njegovi prolijekovi za liječenje psihijatrijskih poremećaja | |
| EP3639859A4 (en) | ORAL MEDICINAL DELIVERY COMPOSITION WITH OXALIPLATIN AND MANUFACTURING METHOD FOR IT | |
| RU2018127013A (ru) | Лекарственное средство, содержащее арипипразол и цилостазол |